TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Key Financials
Gross Profit
$8.9B
↑ 10.8%
Operating Income
$2.2B
↑ 811.9%
Net Income
$1.4B
↑ 186.0%
EPS (Diluted)
$1.21
↑ 183.4%
Total Assets
$40.7B
↑ 3.6%
Revenue
$1.5B
N/A
Shareholders' Equity
$7.9B
↑ 47.2%
Long-term Debt
$28.8B
↓ 11.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 144 | 5/14/2026 | View on SEC |
| 144 | 5/14/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 4 | 5/7/2026 | View on SEC |
| 144 | 5/5/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 4 | 5/4/2026 | View on SEC |
| 144 | 5/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TEVA |
| Company Name | TEVA PHARMACEUTICAL INDUSTRIES LTD |
| CIK | 818686 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 972 (3) 914-8213 |